ESEF — Europäische Jahresabschlüsse (iXBRL) fact · reporting period
NOVOZYMES A/S: cashflow_financing
One fact, its scope and the complete path back to the official record.
Reported value
855.400M{"amount": 855400000.0, "concept": "ifrs-full:CashFlowsFromUsedInFinancingActivities"}- Entity
- NOVOZYMES A/S
- Metric
- cashflow_financing
- Period
- 2025-01-01 – 2025-09-30
- Status
- current
- Source
- ESEF — Europäische Jahresabschlüsse (iXBRL)
Provenance
Official reference
esef:529900T6WNZXD2R3JW38:2025-09-30Source licensePublic filings (ESEF-Verordnung)
Retrieved2026-08-23T22:58:36.155006+02:00
Raw response SHA-256
8b248b9feb6411f0562ee0aad5df7ead…History
- no predecessors — first report
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.